vTv Therapeutics (VTVT) Accumulated Depreciation (2014 - 2021)

vTv Therapeutics has disclosed Accumulated Depreciation across 8 years of filings, most recently posting $305000.0 for Q4 2021.

• Accumulated Depreciation for Q4 2021 came in at $305000.0, up 41.2% year-over-year; the trailing twelve-month figure through Dec 2021 was $305000.0 (up 41.2% YoY), and the FY2021 annual result was $305000.0, up 41.2% from the prior year.
• Accumulated Depreciation came in at $305000.0 for Q4 2021 at vTv Therapeutics, up from $216000.0 in the prior quarter.
• In the past five years, Accumulated Depreciation ranged from a high of $9.1 million in Q4 2017 to a low of $148000.0 in Q4 2019.
• The 5-year median for Accumulated Depreciation is $305000.0 (2021), against an average of $3.6 million.
• Across the five-year window, Accumulated Depreciation tumbled 98.24% in 2019 and surged 45.95% in 2020, its largest moves.
• vTv Therapeutics' Accumulated Depreciation stood at $9.1 million in 2017, then decreased by 7.51% to $8.4 million in 2018, then sank by 98.24% to $148000.0 in 2019, then jumped by 45.95% to $216000.0 in 2020, then jumped by 41.2% to $305000.0 in 2021.
• The last three Accumulated Depreciation figures came in at $305000.0 (Q4 2021), $216000.0 (Q4 2020), and $148000.0 (Q4 2019), per Business Quant data.